Bryostatin composition and bryostatin acquisition methodologies

Details Bryostatin composition and bryostatin acquisition methodologies Bryostatin composition and bryostatin acquisition methodologies

2005-05-31

2005-05-31

Trinh, Ba K. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C549S268000

Reexamination Certificate

active

06900339

ABSTRACT:
Methods for obtaining bryostatins from the marine bryozoans of theBugula neritinaspecies complex are provided wherein the methods involve the extraction and purification of bryostatins from the larvae ofBugula neritinaorganisms. Further, the present invention relates to a novel bryostatin composition that can be extracted fromBugula neritina.

REFERENCES:
patent: 4611066 (1986-09-01), Pettit et al.
patent: 0 264 173 (1988-04-01), None
Chemical Abstracts129(21): abstract No. 272958k, p. 392 (1998).
Chemical Abstracts132(2): abstract No. 10835j, p. 267 (1998).
Chemical Abstracts132(26): abstract No. 345544v, p. 381 (1999).
Davidson, “Biology of the Bryostatins in the marine bryozoanBugula neritina: Symbiosis, cryptic speciation and chemical defense,”DissertationUniversity of California, San Diego, Margo G. Haywood, chair (1999).
Davidson et al., “Identification of Sibling Species of the BryozoanBugula neritinaThat Produce Different Anticancer Bryostatins and Harbor Distinct Strains of the Bacterial Symbiont ‘CandidatusEndobugula sertula,’”Biol. Bull.196: 272-280 (Jun. 1999).
Haygood et al., “Bacterial Symbionts of the Bryostatin-Producing BryozoanBugula Neritina,” New Developments in Marine BiotechnologyLe Gal and Halvorson, eds. 281-284 (1998).
Haygood et al., “Small-Subunit rRNA Genes and In Situ Hybridization with Oligonucleotides Specific for the Bacterial Symbionts in the Larvae of the BryozoanBugula neritinaand Proposal ofCandidatusEndobugula sertuna,”Applied and Environmental Microbiology63(11):4612-4616 (Nov. 1997).
“Helping to Cure Cancer Through In-The-Sea Culture of Pharmaceuticals,”NCRI News9(3):3-5 (Jan. 1996).
Houwen et al., “Bryostatin 19: A New Antineoplastic Component fromBugula neritinain the South China Sea,” English abstract (1998).
Houwen et al., “Studies on the Antineoplastic Constituents from Marine BryozoanBugula neritinain the South China Sea,” English abstract (1998).
Houwen et al., “Studies on the Antineoplastic Constituents from Marine BryozoanBugula neritinaInhabiting South China Sea (III): Isolation and Structural Elucidation of bryostatin 10, 11, and 18,” English abstract (2000).
International Search ReportPCT/US03/13447, mailed Sep. 11, 2003.
Lindquist et al., “Palatability and Chemical Defense of Marine Invertebrate Larvae,”Ecological Monographs66(4):431-450 (1996).
Lindquist et al., “Timing of larval release by two Caribbean demosponges,”Marine Ecology Progress Series155: 309-313 (1997).
Lopanik et al., “Chemical and Molecular Characterization of Ontogenetic Shifts in the Chemical Defense inBugula neritina(Bryozoa),” 2002 Ocean Sciences Meeting.
Lopanik et al., “Chemical and molecular characterization of ontogenetic shifts in the chemical defense inBugula neritina(Bryozoa),”31stMarine Benthic Ecology MeetingFlorida State University (Mar. 21-24, 2002).
Lopanik et al., “Chemical defense ofBugula neritina(Bryozoa) larvae by bryostatins,”30thBenthic Ecology MeetingUniversity of New Hampshire (Mar. 15-18, 2001).
Mendola, “Aquacultural Production of Bryostatin 1 and Ecteinascidin 743,”Drugs from the SeaFusetani N, ed.: 120-133 (2000).
Pettit et al, “Antineoplastic Agents. 340. Isolation and Structural Elucidation of Bryostatins 16-18,”J. Nat. Procl.59: 286-289 (1996).
Pettit et al., “Antineoplastic Agents. 224. Isolation and Structure of Neristatin 1,”Journal of the American Chemical Society6693-6695 (1991).
Pettit et al., “Isolation and Structure of Bryostatin,”J. Am. Chem. Soc.104: 6846-6848 (1982).
Pettit et al., “Isolation and Structure of Bryostatins 14 and 15,”Tetrahedron47(22): 3601-3610 (1991).

Affiliated with

Also associated with

Rating

Bryostatin composition and bryostatin acquisition methodologies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bryostatin composition and bryostatin acquisition methodologies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bryostatin composition and bryostatin acquisition methodologies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3373305